Physician profile
Timothy S Mountcastle
NPI 1821015561
$4,264.34
in general payments reported to CMS, 2019-2025
15 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,403 · 2020: $289 · 2021: $325 · 2022: $145 · 2023: $321 · 2024: $337 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,913.08 | 2019-2022 | |
| Abbvie INC. | $436.26 | 2023-2025 | |
| Galderma Laboratories, L.P. | $267.40 | 2019-2025 | Dysport |
| Baxter Healthcare | $133.04 | 2020 | |
| Revance Therapeutics, INC. | $99.01 | 2025 | Daxxify |
| Integra Lifesciences Corporation | $85.43 | 2025 | Integra, Surgimend, Omnigraft |
| Organogenesis INC. | $78.79 | 2023-2024 | Puraply |
| Solta Medical, A Division of Bausch Health US, LLC | $63.95 | 2025 | Clear+Brilliant |
| Axogen | $50.32 | 2022-2023 | Avance Nerve Graft |
| Mentor Worldwide LLC | $33.45 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Boston Scientific Corporation | $29.98 | 2023 | Varithena Administration Pack |
| Tela Bio, INC. | $28.22 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $21.58 | 2025 | Exparel |
| Smith+Nephew, INC. | $12.09 | 2021 | |
| Kerecis Limited | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mountcastle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.